IMG Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
IMG Wealth Management's REGN Position: Q2 2026 in Review
IMG Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 67% in Q2 2026, buying an estimated $1.36K and bringing the position to 5 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #439.
IMG Wealth Management first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.72K in Q4 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- IMG Wealth Management held 5 shares of Regeneron Pharmaceuticals worth $3.12K as of Q2 2026.
- IMG Wealth Management bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up ﹤0.01% of IMG Wealth Management's portfolio in Q2 2026, its #439 holding.
- IMG Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- IMG Wealth Management's Regeneron Pharmaceuticals position peaked at $7.72K in Q4 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.